ULTRAGENYX PHARMACEUTICAL Trademark

Trademark Overview

On Tuesday, April 9, 2013, a trademark application was filed for ULTRAGENYX PHARMACEUTICAL with the United States Patent and Trademark Office. The USPTO has given the ULTRAGENYX PHARMACEUTICAL trademark a serial number of 85898928. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, July 28, 2023. This trademark is owned by Ultragenyx Pharmaceutical Inc.. The ULTRAGENYX PHARMACEUTICAL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
ultragenyx pharmaceutical

General Information

Serial Number85898928
Word MarkULTRAGENYX PHARMACEUTICAL
Filing DateTuesday, April 9, 2013
Status710 - CANCELLED - SECTION 8
Status DateFriday, July 28, 2023
Registration Number5124555
Registration DateTuesday, January 17, 2017
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 8, 2013

Trademark Statements

Description of MarkThe mark consists of the word "ultragenyx" in lower case letters above the word "pharmaceutical". The formative "ultra" and the word "pharmaceutical" are purple and the formative "genyx" is green. The letter "x" in "genyx" is stylized and features an enlongated stroke reaching above and below the word "ultragenyx".
Goods and ServicesPharmaceutical preparations for the treatment of genetic, neuro-muscular, osteopathic, neurologic, oncologic, metabolic, orthopedic, endocrine, and lipid-related conditions, diseases and disorders
Indication of Colors claimedThe color(s) purple and green is/are claimed as a feature of the mark.
Disclaimer with Predetermined Text"PHARMACEUTICAL"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, July 28, 2023
Primary Code005
First Use Anywhere DateMonday, May 23, 2011
First Use In Commerce DateMonday, May 23, 2011

Trademark Owner History

Party NameUltragenyx Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameUltragenyx Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Friday, July 28, 2023CANCELLED SEC. 8 (6-YR)
Monday, January 17, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 17, 2017REGISTERED-PRINCIPAL REGISTER
Friday, December 16, 2016NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, December 15, 2016ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, December 13, 2016STATEMENT OF USE PROCESSING COMPLETE
Monday, December 5, 2016USE AMENDMENT FILED
Monday, December 5, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, May 24, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, May 21, 2016SOU EXTENSION 5 GRANTED
Friday, May 6, 2016SOU EXTENSION 5 FILED
Friday, May 6, 2016SOU TEAS EXTENSION RECEIVED
Thursday, January 14, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 13, 2016SOU EXTENSION 4 GRANTED
Friday, November 13, 2015SOU EXTENSION 4 FILED
Friday, November 13, 2015SOU TEAS EXTENSION RECEIVED
Friday, June 5, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 4, 2015SOU EXTENSION 3 GRANTED
Wednesday, May 27, 2015SOU EXTENSION 3 FILED
Wednesday, May 27, 2015SOU TEAS EXTENSION RECEIVED
Thursday, January 29, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, January 28, 2015SOU EXTENSION 2 GRANTED
Tuesday, December 2, 2014SOU EXTENSION 2 FILED
Wednesday, January 21, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, December 2, 2014SOU TEAS EXTENSION RECEIVED
Wednesday, June 4, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 2, 2014SOU EXTENSION 1 GRANTED
Monday, June 2, 2014SOU EXTENSION 1 FILED
Monday, June 2, 2014SOU TEAS EXTENSION RECEIVED
Tuesday, December 3, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 8, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 8, 2013PUBLISHED FOR OPPOSITION
Wednesday, September 18, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, September 5, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, August 29, 2013ASSIGNED TO LIE
Tuesday, August 20, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 20, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, August 20, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, August 20, 2013EXAMINERS AMENDMENT -WRITTEN
Tuesday, July 23, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, July 23, 2013NON-FINAL ACTION E-MAILED
Tuesday, July 23, 2013NON-FINAL ACTION WRITTEN
Monday, July 22, 2013ASSIGNED TO EXAMINER
Tuesday, April 16, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, April 12, 2013NEW APPLICATION ENTERED

Related Keywords

pharmaceutical ultragenyx lipid endocrine orthopedic related conditions disorders diseases metabolic oncologic genetic